News from Target Ovarian Cancer

Latest news stories

The news contained in this area falls into a number of categories.  You can select the type of news you wish to see using the scroll down bar.  Leaving the selection blank will mean you see all the news, with the most recent item first. News is archived according to date.

Categories include

  • Target Ovarian Cancer
  • Fundraising
  • Research
  • In the media
Microscope sml

22.05.13 In the news: Routine cancer risk gene testing announced A research programme that will lay the foundations for anyone with cancer to have access to genetic testing has been launched with £2.7 million funding from the Wellcome Trust.

Avastin

22.05.13 Avastin too expensive for routine use on the NHS In two separate pieces of final guidance, the National Institute for Health and Care Excellence (NICE) has advised the NHS against funding the drug bevacizumab (Avastin) for advanced ovarian cancer.

The abseil tower - Sarah Crockford 180513

21.05.13 Team Crockers raises over £10,000! Congratulations to the wonderful (and brave) Team Crockers who abseiled down the UK's tallest abseil tower at the National Abseil Centre in Northampton, on Saturday 18th May!

Microscope sml

20.05.13 Today is International Clinical Trials Day Clinical trials are the essential process for the development of life extending cancer therapies. Target Ovarian Cancer is very aware of the fact that there has been no new life extending treatments for ovarian cancer for over 20 years.